Results

Total Results: 9,447 records

Showing results for "cancer".
Users also searched for: colon cancer screening

  1. www.uspreventiveservicestaskforce.org/uspstf/document/letter-to-the-editor-and-response-from-the-evidence-based-practice-center--human-papillomavirus-testing-to-screen-for-cervical-cancer/cervical-cancer-screening-2012
    February 15, 2012 - In this trial 5 , there were proportionally more cancers with cytology because the cotesting:cytology … Human papilllomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and … intraepithelial neoplasia: a randomised controlled trial. … intraepithelial neoplasia: a randomised controlled trial. … Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/exVc75LHoUdnqjY6wYxzGV
    June 01, 2003 - A large primary tumor (> 2 cm) is associated with an increased risk of metastasis. … To find controlled trials of counseling (question 6), we searched MEDLINE using the terms “skin neoplasms … Outcome measure: new skin cancers. … No difference in the incidence of first cancers. … Sunscreen reduced the total incidence of squamous cell cancers but not basal cell cancers.
  3. effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-radiation-therapy-bone-metastases.pdf
    August 01, 2022 - Which patient characteristics (e.g., age, sex, socioeconomic status, histology of the primary tumor) … Consider patient characteristics (e.g., age, sex, socioeconomic status, histology of the primary tumor … The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors-A … Cancers (Basel). 2020 Jul 18;12(7):18. doi: https://dx.doi.org/10.3390/cancers12071950. … Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms.
  4. psnet.ahrq.gov/issue/diagnostic-error-pediatric-cancer
    November 16, 2022 - Study Diagnostic error in pediatric cancer. … Diagnostic Error in Pediatric Cancer. … Diagnostic Error in Pediatric Cancer. … June 10, 2018 Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis … September 7, 2016 Safety and diagnostic accuracy of tumor biopsies in children with cancer
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amended.pdf
    February 07, 2025 - Recurrent cancer, metastatic cancer, early stage (T1aN0 and T1bN0), stage 4 cancer, GEJ cancer patients … stromal tumors (GIST), neuroendocrine tumors, gastric lymphoma, MALToma, other rare gastric cancers … To reduce clinical heterogeneity, we will analyze studies of patients with resectable tumors or who … Key Informants https://effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf … * OR carcinoma* OR malignan* OR neoplas* OR tumor* OR tumour*)):ab,ti,kw) 2 'cancer palliative therapy
  6. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/skin-cancer-screening-july-2016
    July 26, 2016 - nonmelanoma skin cancer (NMSC) (ie, basal cell and squamous cell cancers) or melanoma skin cancer. … Although NMSC represents more than 97% of skin cancers, 1 melanoma skin cancer is the primary public … 1.01 to 2.00 mm, 4.69 (95% CI, 4.24–5.02) for tumors 2.01 to 4.00 mm, and 5.71 (95% CI, 5.10–6.39) for … tumors larger than 4.00 mm. … rather than earlier detection of invasive tumors, in the absence of changes in mortality. 30 , 31
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
    February 01, 2012 - • For single HSCT for high-risk Ewings sarcoma family of tumors, high-risk relapsed Wilm’s tumor, … and risk of second cancers in patients who have undergone stem cell transplant for cancer. … neoplasms. … LYSATE-PULSED DENDRITIC VACCINE FOR HIGH-RISK SOLID TUMORS A Pilot Study of Tumor Cell Vaccine … for High-risk Solid Tumor Patients Following Stem Cell Transplantation; University of Michigan Cancer
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
    January 01, 2024 - intended to inform primarily medical oncologists, alongside members of multidisciplinary teams and tumor … Recurrent cancer, metastatic cancer, early stage (T1aN0 and T1bN0), stage 4 cancer, GEJ cancer patients … stromal tumors (GIST), neuroendocrine tumors, gastric lymphoma, MALToma, other rare gastric cancers … To reduce clinical heterogeneity, we will analyze studies of patients with resectable tumors or who … * OR carcinoma* OR malignan* OR neoplas* OR tumor* OR tumour*)):ab,ti,kw) 2 'cancer palliative therapy
  9. www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-2002
    June 13, 2002 - More than 80% of colorectal cancers arise from adenomatous polyps. … Annual screening with hydrated specimens detected 49% of all incident cancers, but 38% of all subjects … Small and flat polyps are less well visualized on CT colography than are cancers and large polyps. … Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. … Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
    February 01, 2012 - Adenoma—Benign tumor from epithelial tissue. … Stool DNA and occult blood testing for screen detection of colorectal neoplasia. … Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia … Detection of stool DNA mutations before and after treatment of colorectal neoplasia. … Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-d.xlsx
    January 01, 2023 - ROB 2 Study name Applicable outcome Randomization process Deviations from intended interventions Missing outcome data Measurement of the outcome Selection of the reported result Overall Comments ACTS-GC OS Low Low Low Low Low Low Low in all domains ACTS-GC Grade 3 to 5 AEs Low Low Low Low Low Low Low in all domains …
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
    August 01, 2012 - For women with early invasive cancers, therapy was highest for women treated with BCS+RT and lowest … .1 Most breast cancers (about 75%) contain significant numbers of estrogen receptors (this is called … Use was lowest among women with ER- tumors. Use did not vary greatly across tumor size or grade. … For both groups, use was highest among women with ER+ tumors but was similar for women whose tumors … It appears that while rates of use are higher for women with early invasive cancers than for DCIS,
  13. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-collaborative-modeling-of-us-breast-cancer-/breast-cancer-screening-january-2016
    January 11, 2016 - Models M and W also assumed some small nonprogressive invasive cancers. … for invasive cancers only). … Those with HER2-positive tumors also received trastuzumab. … The MISCAN-Fadia continuous tumor growth model for breast cancer. … Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
    June 01, 2013 - compared with other common cancers. … (KQ 1, KQ 2, and KQ 3); breast, cervical, colorectal, and endometrial cancers (KQ 4 and KQ 5); and … outcomes (KQ 1, KQ 2, KQ 3), 66 to other cancers of interest (KQ 4, KQ 5), and 50 to vascular events … Increase or decrease in age-specific incidence of cancers in ever OC users versus never users Figure … (decreased risk of ovarian, colorectal, and endometrial cancers) associated with OC use can affect
  15. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/43578/psn-pdf
    October 01, 2014 - Some cancer experts see 'overdiagnosis,' question emphasis on early detection. … https://psnet.ahrq.gov/issue/some-cancer-experts-see-overdiagnosis-question-emphasis-early-detection … of tumors that may never cause harm, this newspaper article discusses the impact of unnecessary tests … Researchers are working to design better tests to distinguish between benign abnormalities and cancers … https://psnet.ahrq.gov/issue/some-cancer-experts-see-overdiagnosis-question-emphasis-early-detection
  16. psnet.ahrq.gov/issue/how-timely-diagnosis-lung-cancer-cohort-study-individuals-lung-cancer-presenting-ambulatory
    September 14, 2022 - How timely is diagnosis of lung cancer? … Cancers (Basel). 2022;14(23):5756. doi:10.3390/cancers14235756. … Cancers (Basel) . 2022; 14 (23) :5756 . View more articles from the same authors. … How timely is diagnosis of lung cancer? … Cancers (Basel). 2022;14(23):5756. doi:10.3390/cancers14235756.
  17. hcup-us.ahrq.gov/reports/statbriefs/sb153.pdf
    March 01, 2013 - Excludes cancers and nonspecific CCS categories. 4 Table 2. … Excludes cancers and nonspecific CCS categories. 5 Figure 1 shows that readmission rates … , other primary 6,146 1,781 29.0 42 Secondary malignancies 177,796 44,647 25.1 43 Malignant neoplasm … without specification of site 6,636 1,670 25.2 44 Neoplasms of unspecified nature or uncertain behavior … 42,002 9,551 22.7 45 Maintenance chemotherapy, radiotherapy 126,113 82,601 65.5 46 Benign neoplasm
  18. hcup-us.ahrq.gov/reports/statbriefs/sb153.jsp
    April 01, 2013 - Excludes cancers and nonspecific CCS categories. Table 2. … Excludes cancers and nonspecific CCS categories. … , other primary 6,146 1,781 29.0 42 Secondary malignancies 177,796 44,647 25.1 … 43 Malignant neoplasm without specification of site 6,636 1,670 25.2 44 Neoplasms … 9,551 22.7 45 Maintenance chemotherapy, radiotherapy 126,113 82,601 65.5 46 Benign
  19. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006_MaskedStats_Core_Weighted.PDF
    January 01, 2006 - 1065 0.00 29: Cancer of prostate 9856 0.01 30: Cancer of testis 999 0.00 31: Cancer of other male … ; other and unspecified primary 3348 0.00 42: Secondary malignancies 134808 0.11 43: Malignant neoplasm … without specification of site 5032 0.00 44: Neoplasms of unspecified nature or uncertain behavior 32819 … 0.03 45: Maintenance chemotherapy; radiotherapy 3822 0.00 46: Benign neoplasm of uterus 31428 0.03 … 47: Other and unspecified benign neoplasm 51974 0.04 48: Thyroid disorders 38149 0.03 49: Diabetes
  20. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006v2_MaskedStats_Core_Weighted.PDF
    January 01, 2019 - 965 0.00 29: Cancer of prostate 9582 0.01 30: Cancer of testis 890 0.00 31: Cancer of other male … ; other and unspecified primary 3604 0.00 42: Secondary malignancies 137580 0.11 43: Malignant neoplasm … without specification of site 4843 0.00 44: Neoplasms of unspecified nature or uncertain behavior 33568 … 0.03 45: Maintenance chemotherapy; radiotherapy 3698 0.00 46: Benign neoplasm of uterus 30192 0.03 … 47: Other and unspecified benign neoplasm 51580 0.04 48: Thyroid disorders 36347 0.03 49: Diabetes